Thomas Olin
Director Técnico/Científico/I+D en KANCERA AB .
Cargos activos de Thomas Olin
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KANCERA AB | Director Técnico/Científico/I+D | 01/07/2023 | - |
| Director/Miembro de la Junta | 05/05/2010 | 01/07/2023 | |
| Director Ejecutivo | - | 01/07/2023 | |
| Contacto de Relaciones con Inversores | - | 01/07/2023 | |
| Public Communications Contact | - | 01/07/2023 | |
iNovacia AB
 iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Director Ejecutivo | 01/01/2006 | - |
| Blasieholmen Investment Group AB | Director/Miembro de la Junta | - | - |
Historial de carrera de Thomas Olin
Antiguos cargos conocidos de Thomas Olin.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KLARIA PHARMA HOLDING AB | Director/Miembro de la Junta | - | - |
| Independent Dir/Board Member | - | - | |
| Pharmacia Hospital Care | Corporate Officer/Principal | - | - |
| SALTX TECHNOLOGY HOLDING AB | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | - | - | |
| Pharmacia & Upjohn, Inc. | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
| Suecia | 6 |
| Estados Unidos | 2 |
| Dinamarca | 2 |
Operativa
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| Corporate Officer/Principal | 2 |
Sectorial
| Health Technology | 4 |
| Commercial Services | 2 |
| Electronic Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| KANCERA AB | Health Technology |
| SALTX TECHNOLOGY HOLDING AB | Electronic Technology |
| KLARIA PHARMA HOLDING AB | Health Technology |
| Empresas privadas | 4 |
|---|---|
| Pharmacia & Upjohn, Inc. | Health Technology |
| Pharmacia Hospital Care | |
iNovacia AB
iNovacia AB Miscellaneous Commercial ServicesCommercial Services Part of Kancera AB, iNovacia AB is a Swedish company that provides pre-clinical research services. The company is based in Stockholm, Sweden. The company was founded by Martin Norin, Carl Johan Kördel, Philippe Verwaerde. Thomas Olin has been the CEO of the company since 2006. iNovacia was acquired by Kancera AB on February 17, 2011 for $0.05 million. | Commercial Services |
| Blasieholmen Investment Group AB |
- Bolsa de valores
- Insiders
- Thomas Olin
- Experiencia
